Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong-June Kim

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 24, 2012
Epigenetics of bladder cancerWun-Jae Kim, Yong-June Kim
Investigative and Clinical Urology|June 22, 2016
Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?Yong-June Kim, Wun-Jae Kim
Expert Review of Molecular Diagnostics|April 22, 2009
Epigenetic biomarkers in urothelial bladder cancerWun-Jae Kim, Yong-June Kim
Translational Oncogenomics|May 4, 2013
Epigenetic markers for bladder cancer in urineWun-Jae Kim, Yong-June Kim
Annals of Translational Medicine|February 5, 2020
The prognostic significance of preexisting diabetes in patients with surgically treated renal cell carcinoma: the ongoing debateHo Won Kang, Yong-June Kim
Biomarker Insights|August 8, 2009
Biomarkers in bladder cancer: present status and perspectivesWun-Jae Kim, Soongang Park, Yong-June Kim
Journal of Gastrointestinal Oncology|July 20, 2012
Effectiveness of radiation therapy in GIST: A case reportJoshua Halpern, Yong-June Kim, Rumana Sultana, et al.
Biosensors & Bioelectronics|February 18, 2018
Electrochemical detection of methylated DNA on a microfluidic chip with nanoelectrokinetic pre-concentrationSung A Hong, Yong-June Kim, Sung Jae Kim, et al.
Journal of Personalized Medicine|October 25, 2024
A 5-Year Mortality Prediction Model for Prostate Cancer Patients Based on the Korean Nationwide Health Insurance Claims DatabaseJoungyoun Kim, Yong-Hoon Kim, Yong-June Kim, et al.
Cancers|September 28, 2021
Integrative Transcriptome Profiling Reveals <i>SKA3</i> as a Novel Prognostic Marker in Non-Muscle Invasive Bladder CancerChaelin You, Xuan-Mei Piao, Keunsoo Kang, et al.
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Methods in Molecular Biology (Clifton, N.J.)|February 24, 2012
Epigenetics of bladder cancerWun-Jae Kim, Yong-June Kim
Investigative and Clinical Urology|June 22, 2016
Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?Yong-June Kim, Wun-Jae Kim
Expert Review of Molecular Diagnostics|April 22, 2009
Epigenetic biomarkers in urothelial bladder cancerWun-Jae Kim, Yong-June Kim
Translational Oncogenomics|May 4, 2013
Epigenetic markers for bladder cancer in urineWun-Jae Kim, Yong-June Kim
Annals of Translational Medicine|February 5, 2020
The prognostic significance of preexisting diabetes in patients with surgically treated renal cell carcinoma: the ongoing debateHo Won Kang, Yong-June Kim
Biomarker Insights|August 8, 2009
Biomarkers in bladder cancer: present status and perspectivesWun-Jae Kim, Soongang Park, Yong-June Kim
Journal of Gastrointestinal Oncology|July 20, 2012
Effectiveness of radiation therapy in GIST: A case reportJoshua Halpern, Yong-June Kim, Rumana Sultana, et al.
Biosensors & Bioelectronics|February 18, 2018
Electrochemical detection of methylated DNA on a microfluidic chip with nanoelectrokinetic pre-concentrationSung A Hong, Yong-June Kim, Sung Jae Kim, et al.
Journal of Personalized Medicine|October 25, 2024
A 5-Year Mortality Prediction Model for Prostate Cancer Patients Based on the Korean Nationwide Health Insurance Claims DatabaseJoungyoun Kim, Yong-Hoon Kim, Yong-June Kim, et al.
Cancers|September 28, 2021
Integrative Transcriptome Profiling Reveals <i>SKA3</i> as a Novel Prognostic Marker in Non-Muscle Invasive Bladder CancerChaelin You, Xuan-Mei Piao, Keunsoo Kang, et al.
Pageof 16